Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, Anhui Province, China.
Naunyn Schmiedebergs Arch Pharmacol. 2021 Jan;394(1):189-204. doi: 10.1007/s00210-020-01891-5. Epub 2020 May 30.
The study was to explore the hepatoprotective effect and possible mechanism of calycosin on carbon tetrachloride (CCl)-induced liver fibrosis in mice. Hepatic fibrosis was induced by intraperitoneal injection of CCl in C57BL/6 male mice. Serum alanine aminotransferase (ALT) and aspartate transaminase (AST) activity, superoxide dismutase (SOD) activity, and hydroxyproline (Hyp) and malondialdehyde (MDA) levels were determined by biochemical assays. Liver histopathology was assessed by H&E and Masson trichrome staining. The mRNA expressions of α-smooth muscle actin (α-SMA), collagen-I (Col-I), Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) were determined using qRT-PCR. The protein levels of α-SMA, Col-I, estrogen receptor α (ERα), estrogen receptor β (ERβ), tissue inhibitor of metalloproteinase-1 (TIMP-1), matrix metalloproteinase-1 (MMP-1), JAK2, phospho-JAK2 (p-JAK2), STAT3, and phospho-STAT3 (p-STAT3) were detected by Western blotting. The levels of α-SMA and ERβ were measured by immunohistochemistry. Calycosin significantly reduced liver index, MDA level, and ALT and AST activity and increased SOD activity. The α-SMA, Col-I, and Hyp of the calycosin group were significantly lower than those of the model group. Calycosin increased MMP-1 and inhibited TIMP-1 expression resulting in the improvement of MMP-1/TIMP-1 ratio. Importantly, calycosin improved ERβ protein expression, JAK2 and STAT3 mRNA expressions, p-JAK2/JAK2, and p-STAT3/STAT3 relative protein expressions. However, ERα, JAK2, and STAT3 protein expressions were relatively unchanged. Calycosin significantly inhibits liver fibrosis in mice, and its mechanism may involve the following: calycosin inhibits oxidative stress; calycosin inhibits collagen synthesis and balances MMP-1/TIMP-1 system; calycosin increases ERβ expression and activates JAK2-STAT3 pathway.
本研究旨在探讨毛蕊异黄酮对四氯化碳(CCl)诱导的小鼠肝纤维化的保护作用及其可能机制。通过腹腔注射 CCl 诱导 C57BL/6 雄性小鼠肝纤维化。采用生化分析测定血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)活性、超氧化物歧化酶(SOD)活性以及羟脯氨酸(Hyp)和丙二醛(MDA)水平。通过 H&E 和 Masson 三色染色评估肝组织病理学变化。采用 qRT-PCR 检测α-平滑肌肌动蛋白(α-SMA)、I 型胶原(Col-I)、Janus 激酶 2(JAK2)和信号转导和转录激活因子 3(STAT3)的 mRNA 表达水平。采用 Western blot 检测 α-SMA、Col-I、雌激素受体α(ERα)、雌激素受体β(ERβ)、金属蛋白酶组织抑制剂-1(TIMP-1)、基质金属蛋白酶-1(MMP-1)、JAK2、磷酸化-JAK2(p-JAK2)、STAT3 和磷酸化-STAT3(p-STAT3)的蛋白水平。采用免疫组化法检测 α-SMA 和 ERβ 的水平。毛蕊异黄酮可显著降低肝指数、MDA 水平及 ALT 和 AST 活性,提高 SOD 活性。毛蕊异黄酮组的α-SMA、Col-I 和 Hyp 明显低于模型组。毛蕊异黄酮增加 MMP-1 表达,抑制 TIMP-1 表达,从而改善 MMP-1/TIMP-1 比值。重要的是,毛蕊异黄酮可改善 ERβ 蛋白表达,增加 JAK2 和 STAT3 mRNA 表达,下调 p-JAK2/JAK2 和 p-STAT3/STAT3 相对蛋白表达。然而,ERα、JAK2 和 STAT3 蛋白表达相对不变。毛蕊异黄酮可显著抑制小鼠肝纤维化,其机制可能涉及以下几个方面:毛蕊异黄酮抑制氧化应激;毛蕊异黄酮抑制胶原合成并平衡 MMP-1/TIMP-1 系统;毛蕊异黄酮增加 ERβ 表达并激活 JAK2-STAT3 通路。